期刊文献+

贝那普利对兔急性心肌梗死再灌注后内皮素-1及无复流的影响 被引量:2

Effects of benazepril on endothelin-1 and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion
下载PDF
导出
摘要 目的评价贝那普利对兔急性心肌梗死(AMI)再灌注后内皮素-1(endothelin-1,ET-1)的影响及对无复流的防治作用。方法新西兰大白兔24只随机分成对照组、贝那普利组[3 mg/(kg.d)]和假手术组,每组8只。将冠状动脉结扎60 min、松解120 min,制备AMI再灌注模型。梗死前、后和再灌注后,用导管法进行血液动力学测定。采用放射免疫测定法检测血浆及心肌组织中ET-1的水平,最终进行病理学分析。结果与对照组相比,贝那普利组能明显降低兔AMI再灌注后血浆ET-1的水平(P<0.01);而心肌组织中ET-1的含量仅复流区显著降低(P<0.01)。与对照组相比,贝那普利可促进AMI后心功能的恢复,减少无复流的面积[对照组为75.3%结扎区(LA),贝那普利组为35.9%LA,P<0.01]。结论贝那普利能有效降低血浆及心肌组织中ET-1的水平,具有内皮保护作用;能有效地防治心肌梗死再灌注后无复流现象的发生。 AIM To evaluate the effects of benazepril on myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion. METHODS Twenty-four rabbits were divided randomly into 3 groups ( 8 each group), namely, control group, benazepril 13 mg/( kg·d) 1 group and sham operation group. The animals in the former two groups were subjected to a 60 minute coronary occlusion, followed by a 120 minute reperfusion. Data on haemodynamics were collected and the levels of ET-1 in blood samples and myoeardium were determined by radioimmunoassay (RIA). The areas of no-reflow were evaluated with pathological means. RESULTS In benazepril group, the levels of plasma ET-1 were significantly lower than those in the control group (P 〈0. 01 ), whereas the level of ET-1 in infarcted reflow myocardium was significantly lower than that in the control group (P 〈 0.01 ). In the control group, the area of no-reflow was 75.3% of ligation area(LA) , whereas the area was significantly decreased to 35.9% of LA in benazepril group (P 〈0. 01 ). CONCLUSION Benazepril is effective in reducing ET-1 in blood plasma and local myocardium and protecting endothelial cells. Benazepril also has some beneficial effects on preventing myocardial no-reflow, improving left ventrieular function and reducing infarcted area during acute myocardial infarction and reperfusion in rabbits.
出处 《心脏杂志》 CAS 2008年第5期521-524,共4页 Chinese Heart Journal
关键词 心肌梗死 再灌注 无复流现象 贝那普利 内皮素-1 myocardial infarction reperfusion no-refl ow phenomenon benazepril edothelin-1
  • 相关文献

参考文献10

  • 1Brosh D, Assali AR, Mager A, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality[J]. Am J Cardiol, 2007, 99(4) :442 - 445.
  • 2Pernow J, Wang QD. Endothelin in ischaemia and reperfusion[ J]. Cardiovasc Res, 1997, 33(3) :518 -526.
  • 3Mancini GB, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND ( trial on reversing endothelial dysfunction) study[ J]. Circulation, 1996, 94(3) :258 -265.
  • 4Reffelmann T, Kloner RA. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit[ J]. Am J Physiol Heart Circ Physiol, 2002, 283 ( 3 ) : H1099 - H1107.
  • 5Dzau V J, Bernstein K, Celermajer D, et al. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data[J]. Am J Cardiol, 2001, 88(9A) :1L -20L.
  • 6Lazar HL, Bao Y, Rivers S, et al. Pretreatment with angiotensinconverting enzyme inhibitors attenuates ischemia-reperfusion injury [J]. Ann Thorac Surg, 2002, 73(5) :1522 -1527.
  • 7赵京林,杨跃进,尤士杰,荆志成,吴永建,杨伟宪,陈纪林,高润林,陈在嘉.腺苷对猪急性心肌梗死再灌注后内皮素-1的影响[J].中国医学科学院学报,2006,28(2):225-229. 被引量:8
  • 8Tiefenbacher CP, Friedrich S, Bleeke T, et al. ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles[J]. Am J Physiol Heart Circ Physiol, 2004, 286(4): H1425 - H1432.
  • 9Herrmann J. Peri-procedural myocardial injury: 2005 update [ J ]. Eur Heart J, 2005, 26(23) :2493 -2519.
  • 10杨文,杨桂娥.血管紧张素转换酶抑制剂对心肌梗死后血浆纤维蛋白原的影响[J].心脏杂志,2003,15(2):184-184. 被引量:2

二级参考文献23

  • 1赵京林,杨跃进,荆志成,吴永建,尤士杰,杨伟宪,孟亮,田毅,陈纪林,高润霖,陈在嘉.腺苷对猪急性心肌梗死再灌注后无再流的影响[J].中华心血管病杂志,2005,33(5):453-458. 被引量:10
  • 2Eeckhout E,Kern MJ.The coronary no-reflow phenomenon:a review of mechenism and therapies.Eur Heart J,2001,22(29):729-739.
  • 3Pernow J,Wang QD.Endothelin in ischaemia and reperfusion.Cardiovasc Res,1997,33(3):518-526.
  • 4Lim SY,Bae EH,Jeong MH,et al.Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.Circ J,2004,68(10):928-932.
  • 5Rosales OR,Eades B,Assali AR,et al.Cardiovascular drugs:adenosine role in coronary syndromes and percutaneous coronary interventions.Catheter Cardiovasc Interv,2004,62(3):358-363.
  • 6Yanagisawa M,Kurihara H,Kimura S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells.Nature,1988,332(6163):411-415.
  • 7Velasco CE,Turner M,Inagami T1,et al.Reperfusion enhance the local release of endothelin after regional myocardial ischemia.Am Heart J,1994,128(3):441-451.
  • 8Ishida K,Takeshige K,Minakami S.Endothelin-1 enhances superroxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methiony-leucyl-phenylalanin.Biochemi Biophys Res Commu,1990,173(2):496-501.
  • 9Nayler WG.Calcium antagonists and the ischaemic myocardium.Int J Cardiol,1987,15(3):267-285.
  • 10Taylor AJ,Bobik A,Richards M.Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease.Am Heart J,2004,148(2):e10.

共引文献8

同被引文献24

  • 1杨军,方毅民,李善春,于滨,刘少荣.川芎嗪对急性心肌梗死血运重建后“心肌无复流”患者心肌组织灌注的影响[J].中国微循环,2006,10(2):89-91. 被引量:10
  • 2Brosh D, AssaliAR, MagerA, et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality [ J ]. Am J Cardiol,2007,99 (4) :442-445.
  • 3Neri Serneri GG, Boddi M, biodesti PA, et al. Cardiac angiotensin I! participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component[ J]. Circ Res,2004, 94(12) :1630-7.
  • 4Yeh ET, Anderson HV, Pascefi V, et al. C-reactive protein:linking inflammation to cardiovascular complications [ J ]. Circulation, 2001, 104(9) :974-975.
  • 5Herskowitz A, Choi S, Ansari AA, et al. Cytokine mRNA expression in postischemic/reperfused myocardium [ J ]. Am J Pathol, 1995,146 (2) :419-28.
  • 6Villard E, Alonso A, Agrapart M, et al. Induction of angiotensin I-converting enzyme transcription by a protein kinase C-dependent mechanism in human endothelial ceils [ J ]. J Biol Chem, 1998,273 (39) :25191-25197.
  • 7GttrgtinC, Ildl zll M, Yavuzgil O, et al. The effects of short term statin treatment on left ventricular function and inflammatory markers in pa- tients with chronic heart failure [ J ]. Iut J Cardiol,2008,123 ( 2 ) : 102 - 107.
  • 8Kinlay S, Schwartz GG, Olsson AG, et al. High-dose atorvastatin en- hance the decline in inflammatory markers in patients with a cute coro- nary syndromes in the MIRACL study [ J ]. Circulation, 2003,108 ( 13 ) : 1560-1566.
  • 9Halkin A, Keren G. Potential indications for angiotensin-converting en- zyme inhibitors in atherosclerotic vascular disease [ J ]. Am J Med, 2002,112(2) :126-134.
  • 10Auch-Schwelk W, Bossaller C, Claus M, et al. ACE inhibitors are endothelium dependent vasodilators of coronary arteries during sub- maximal stimulation with bradykinin [ J ]. Cardiovasc Res, 1993,27 (2) :312-317.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部